ABSTRACT Introduction Hepatitis C virus (HCV) infection is associated with an increased
incidence and progression of chronic kidney disease (CKD), as well as higher mortality in …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

Several single-center reports of using HCV-viremic organs for HCV-uninfected (HCV-)
recipients were recently published. We sought to characterize national utilization of HCV …

The management of HCV infection in kidney transplantation presents significant challenges.
HCV, left untreated, worsens patient and graft survival after kidney transplantation through …

Direct-acting antivirals approved for use in patients with end-stage renal disease (ESRD)
now exist. HCV-positive (HCV+) ESRD patients have the opportunity to decrease the waiting …

Patients with end-stage renal disease (ESRD) who are coinfected with hepatitis C virus
(HCV) and human immunodeficiency virus (HIV) have access to effective treatment options …

Background Patients who undergo hemodialysis (HD) or kidney transplantation (KTx)
previously had limited possibilities for treatment of hepatitis C virus (HCV) infection. Direct …

Chronic hepatitis C virus (HCV) infection continues to be transmitted to hemodialysis (HD)
patients within HD facilities globally. The World Health Organization's (WHO) goal to micro …

Hepatitis C virus (HCV) infection is one of the major global health burdens. Chronic HCV
infection can increase the risks of proteinuria and chronic kidney disease (CKD), as well as …

The prevalence of hepatitis C virus infection is increased in patients with end stage kidney
disease compared to the general population and is an adverse outcome determinant. Direct …